Mar 23, 2022 / 01:45PM GMT
Matthew Ian Mishan - KeyBanc Capital Markets Inc., Research Division - VP & Senior Equity Research Analyst
Good morning. I'd like to welcome everyone to the second day of the KeyBank Life Sciences & MedTech Investor Forum. My name is Matt Mishan. I'm our senior med tech analyst, and I'm pleased to be joined by Teleflex, who is represented today by Thomas Powell, EVP and CFO; and Larry Keusch, VP of IR and Strategy Development.
For the audience, I'll start us off. (Operator Instructions) Tom, Larry, thank you very much for joining us.
Questions and Answers:
Matthew Ian Mishan - KeyBanc Capital Markets Inc., Research Division - VP & Senior Equity Research AnalystI'll start off with a macro question to start. I believe there's just a lot of disconnected moving pieces right now, and it's hard to see the bigger picture, which is a challenge. And just to level set, what's most important for your business from a macro perspective? And kind of where is management spending the most time at this point?
Thomas E. Powell